ASAxel Schmermund

Axel Schmermund

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Axel Schmermund has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Zusammenhang zwischen moderater körperlicher Aktivität und dem Ausmaß koronarer Verkalkung - Ergebnisse der Heinz Nixdorf Recall Studie

    by S Andrich, N Dragano, S Möhlenkamp, A Schmermund, N Lehmann, U Slomiany, U Roggenbuck, J Siegrist, Kh Jöckel, R Erbel, et al.

    Hintergrund: Für die Prävention koronarer Herzerkrankungen (KHK) ist körperliche Aktivität von besonderer Bedeutung. Um möglichst viele Personen anzusprechen, werden auch moderate Alltagsaktivitäten (z.B. Gartenarbeit, Spazieren gehen oder Fahrrad fahren) zur Ausübung empfohlen. Ziel ist zu prüfen, ob es eine Assoziation zwischen „körperlicher Aktivität“ und dem Verkalkungsgrad der Koronararterien gibt. Methoden: Ausgewertet werden Querschnittsdaten (2000–2003) einer Subpopulation von 2048 Probanden (45–75 Jahre, 50,1% Männer, keine KHK) der bevölkerungsbasierten Heinz Nixdorf Recall Studie. Um nur körperliche Aktivitäten zu betrachten, sind Personen die aktiv Sport treiben ausgeschlossen worden. Die Analyse vergleicht Probanden, die gar keine körperliche Aktivität ausüben (Inaktive) mit Personen, die ausschließlich körperliche Aktivitäten angegeben haben. Sport und körperliche Aktivität wurden per Interview erfasst Koronarkalk (CAC) wurde mittels Elektronenstrahl-CT gemessen. In geschlechtsspezifischen log-binomialen Regressionsanalysen (Proc Genmod) wurden Prävalenz Ratios (PR) und 95%-Konfidenzintervalle geschätzt mit CAC (dichotomisiert >75. alters- und geschlechtsspezifisches Perzentil) als Outcome und körperlicher Aktivität (aktiv vs. inaktiv) als Exposition, adjustiert für Alter, Diabetes, Blutdruck, Blutfette, Rauchstatus, BMI und Schulbildung. Ergebnisse: Ein hoher Anteil der Probanden übt körperliche Aktivität aus (Männer: 89,2%, Frauen: 86,8%). Ein wesentlicher Gruppenunterschied (aktiv vs. inaktiv) lässt sich bei den Männern hinsichtlich des Risikofaktors Rauchen konstatieren: Unter körperlich Aktiven sind mehr Ex-Raucher (42,2% vs. 33,6%), hingegen deutlich weniger Raucher (30,1% vs. 50,0%) zu finden. Zudem nehmen körperlich aktive Männer häufiger Antihypertensiva ein (34,1% vs. 27,0%). Für körperlich aktive Frauen fällt auf, dass sie häufiger Nichtraucher sind (56,3% vs. 43,7%). Während der Koronarkalk im Median für Männer bei den körperlich Aktiven etwas höher ist, besteht kein Unterschied zwischen aktiven und inaktiven Frauen. In geschlechtsspezifischen adjustierten Regressionsanalysen zeigen sich erhöhte, statistisch nicht signifikante PR für körperlich Aktive (Männer: PR 1,14 95%-CI: 0,81–1,63, Frauen: 1,25 0,92–1,70). Schlussfolgerungen: Die Querschnittanalysen zeigen eine unerwartete Richtung der Assoziation. Zur Einordnung der Ergebnisse müssen mögliche strukturelle Unterschiede in der Gruppenzusammensetzung beachtet werden. Literatur: Schmermund, A., Möhlenkamp, S., Stang, A., Grönemeyer, D., Seibel, R., Hirche, H., Mann, K., Siffert, W., Lauterbach, K., Siegrist, J., Jöckel, K. H., Erbel, R. (2002): Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf Recall Study. American Heart Journal, 144, 212–218. Thompson, P. D., Buchner, D., Piña, I. L., Balady G. J., Williams, M. A., Marcus, B. H., Berra, K., Blair, S. N., Costa, F., Franklin, B., Fletcher, G. F., Gordon, N. F., Pate, R. R., Rodriguez, B. L., Yancey, A. K., Wengerm N. K. (2003): Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease: A Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation, 107, 3109–3116.


  • Improved risk prediction of myocardial Infarction and coronary death based on quantification of subclinical coronary atherosclerosis – Results of the Heinz Nixdorf Recall study

    by R Erbel, S Möhlenkamp, S Moebus, N Lehmann, A Stang, A Schmermund, H Kälsch, D Grönemeyer, R Seibel, K Mann, et al.

    Background: Coronary artery calcium (CAC) has been suggested to improve prediction of coronary events beyond traditional risk factor assessment. We determined whether CAC scoring improves prediction of coronary events when added to traditional risk factor analysis in the general population. Methods: We used data of the Heinz Nixdorf Recall cohort study, including 4129 randomly selected subjects aged 59.4±7.7 years (53% women) without overt coronary artery disease at baseline (2000 to 2003). Traditional risk factors and CAC, measured by electron-beam computed tomography, were assessed. Participants were stratified into low, intermediate or high risk categories using the Framingham risk score (FRS), and modified ATPIII risk score categories (modATPIII). Participants were followed for hard coronary events, i.e. coronary death and non-fatal myocardial infarction for 5.02 years. Results: The cumulative event rate was 2.3% (95% confidence intervals (CI): 1.8–2.8). Relative risks (RR) increased from the lowest to the intermediate and highest FRS and modATPIII risk categories. Crude and modATPIII-adjusted RRs in the highest versus lowest CAC quartile were 6.40 (95% CI: 3.37–12.16) and 4.25 (95% CI: 2.14–8.45), respectively. Adding CAC scores to the FRS and modATPIII-categories significantly improved the areas under the ROC curves from 0.681 and 0.667 to 0.749 (p=0.003) and 0.753 (p=0.0001), respectively. Intermediate modATPIII risk subjects with CACConclusion: CAC scoring improves risk stratification in the general population above and beyond traditional risk factors. Adding CAC scoring to the FRS results in a reclassification improvement of coronary risk, especially when focused on intermediate risk individuals.


  • Predictive value of coronary artery calcification and hs-CRP for myocardial infarction and coronary death – Results from the Heinz Nixdorf Recall Study

    by S Moebus, S Möhlenkamp, N Lehmann, A Stang, A Schmermund, N Dragano, H Kälsch, K Jöckel, R Erbel

    Background: High sensitive C-reactive protein (hs-CRP) and coronary artery calcium (CAC) are both associated with impaired outcome in individuals at risk of cardiovascular events. Here we analyzed the predictive value of their combined assessment in a population-based cohort of men and women living in the metropolitan Ruhr area. Methods: CAC, hs-CRP and Framingham risk score (FRS) variables were measured in 3969 persons (aged 59±8 years, 53% women) without known coronary artery disease at baseline. Individuals with acute inflammation (hs-CRP>10.0mg/L) were excluded. All individuals were followed for 5 years for the occurrence of coronary death and non-fatal myocardial 3/≤infarction. Categories of low/high risk were defined as hs-CRP: >3mg/L; CAC: Results: Individuals with events (n=91) versus those without had higher hs-CRP values (median (Q1-Q3): 2.1 (0.9–4.8) versus 1.4 (0.7–2.9), p=0.0007) and higher CAC scores (median (Q1-Q3): 182 (31–982) versus 11 (0–105)). In a multiple logistic model for events including the FRS, hs-CRP, logarithmic transformed CAC, [log(CAC+1)], and cardiovascular medication, hs-CRP, CAC and the FRS remained independent predictors of events (estimates (95% CI): hs-CRP: 1.09 (1.01–1.19), log(CAC+1): 1.39 (1.25–1.55), FRS: 1.03 (1.01–1.05)). Adjusted relative risk in risk categories II, III, and IV compared to risk category I were 2.06 (1.05–4.04), 3.32 (1.92–5.72), and 5.54 (3.01–10.18) respectively. The combined hs-CRP+CAC risk categories (I-IV) further stratified risk within each FRS category (low, intermediate and high risk) allowing for reclassification of risk in up to 56% of intermediate risk individuals. Conclusion: Combined quantification of subclinical atherosclerosis burden and marker of inflammation strongly predicts coronary events, and improves risk assessment in each FRS category.

  • Integration eines neuen Risikomarkers in die kardiovaskuläre Prävention: Beispiel Koronarkalk

    by S Möhlenkamp, N Lehmann, S Moebus, A Schmermund, K.-H Jöckel, R Erbel, Null Für Die Heinz Nixdorf Recall Studiengruppe

    Kardiovaskuläre Prävention - Risikomarker - Koronarkalk cardiovascular prevention - risk marker - coronary artery calcium


    • 28 June 2007
      • Vol. 149, 75-84

    [Current studies on the progression of coronary calcification].

    by S Möhlenkamp, A Schmermund, T Budde, R Erbel

    The quantification of coronary calcification facilitates improved prediction of cardiovascular diseases, in particular in persons with intermediate risk. The importance of serial measurement of coronary calcium in one to two-year intervals for evaluating the course of the disease and therapeutic monitoring after risk modification is unclear. The precise quantification of the progression of arteriosclerosis could contribute to the non-invasive detection of the chronic, often subclinical development of coronary heart disease at an asymptomatic stage of the disease, long before an irreversible clinical event in the pathogenetic cascade, such as sudden cardiac death or myocardial infarction, occurs. An important prerequisite for evaluating changes in the coronary calcium load is detailed knowledge of reproducibility or variability. In addition to a rapid image acquisition time and the use of calibration phantoms, low heart rate and breathing variability, image acquisition in the late systole, overlapping layers (at the expense of radiation dose) and optimized analysis algorithms also contribute to improvement in reproducibility. The limits of variability however are, above all, dependent upon the calcium load itself. Reproducibility is on the average about 10% and thus lies below the highest expected progression, which is about 10-50% per year, depending upon the initial value and pre-existing conditions Only a few studies have identified calcium score progression as an independent predictor for later events. In several studies, calcium score progression was related to the rate of events, but was not independent of other variables. The most important determinant appears to be the calcium score itself. Other relevant determinants are age, gender, diabetes, obesity and renal failure. Whether lipid values significantly influence the progression has not been clarified. Further studies on the natural course of coronary heart disease, particularly in the early disease stages, the determinants of progression and the extent to which the calcification progress can be modified are necessary to assess the benefit of serial score measurement for risk stratification. Until then, the repeated radiation exposure cannot be recommended outside of clinical studies.


    • 31 July 2006
      • Vol. 11  (7) , 267-72

    Intraoperative coronary graft flow determination--does it have a prognostic value for midterm graft patency?

    by S M Cetin, P Massoudy, M Thielmann, C Yildirim, A Schmermund, R Erbel, H Jakob

    To characterise the prognostic value of intraoperative ultrasonic graft flow determination during CABG for mid-term patency. From 01/2000 to 08/2003 3146 CABG procedures were performed at our institution. Graft flow was determined in all patients. Lumen diameter was given in mm and a sclerosis score was applied for the target vessel. 100 of these patients (3.2%) underwent postoperative coronary angiography at a mean time interval of 8.0 +/- 0.5 months. In 100 patients, 114 LITA and 204 venous anastomoses were performed. At re-angiography 112 LITA (98%) and 174 venous (85%) anastomoses were patent. The amount of occluded LITA grafts was to low to perform statistical analyses. Mean graft flow of patent vein grafts was 48 +/- 2 ml/min vs. 32 +/- 4 ml/min in occluded vein grafts (p = 0.001). After multiple logistic regression analysis, only intraoperative vein graft flow was found to be a predictor for patency at mid-term (p = 0.005, odds ratio 0.97, 95% confidence interval (CI) from 0.95-0.99). No differences were found concerning sclerosis scores or vessel lumen between patent and occluded grafts. Significant differences concerning intraoperative graft flow were found between vein grafts patent or occluded at re-angiography. The predictive power of intraoperative vein graft flow for mid-term patency was confirmed by multiple logistic regression analysis.


  • S21.2: Coronary calcium in the general population. First results of the Heinz Nixdorf Recall Studie

    by Susanne Moebus, A. Schmermund, St. Möhlenkamp, A. Stang, K.-H. Jöckel, S. Berenbein, P. Püttmann, D. Grönemeyer, R. Seibel, R. Erbel

  • Correlation of intraoperative graft flow with intermediate term patency as controlled by coronary angiography

    by G Grudev, M Thielmann, P Massoudy, A Schmermund, R Erbel, H Jakob

    Objectives: Determination of graft flow has become routine during CABG procedures. The prognostic value of a specific graft flow with respect to mid- or long-term patency is not clear. We were interested to find a correlation between intraoperative graft flow and patency at re-angiography. Material and Methods: From 01/2000 to 05/2003 2650 CABG procedures were performed at our institution. 93 of the patients (3.5%) underwent postoperative angiography for various reasons. Mean time interval between surgery and angiography was 7.9±0.5 months. In all patients, intraoperative graft flow had been determined using ultrasound technique after termination of ECC. A sclerosis score of 0–3 was applied for the anastomosis and the peripheral vessel. Lumen diameter was given in mm. Results: In 93 patients, 90 left internal thoracic arteries (LITA) and 164 vein grafts were placed. 17 LITA and 33 vein grafts were anastomosed sequentially with at least a second anastomosis, summing up to 107 LITA and 197 venous anastomoses. At the time of angiography 103 LITA (96.6%) and 167 venous (84.7%) anastomoses were patent. Mean flow of patent LITA grafts was 41.7±2 mL/min, occluded LITA grafts had a mean flow of 28.4±10 mL/min (p>0.05). Mean flow of patent vein grafts was 48.4±2 mL/min, occluded vein grafts had a mean flow of 32.1±4 mL/min (p=0.002). No significant differences were found concerning sclerosis scores or lumen between patent and occluded LITA or vein grafts. Conclusions: The severity of sclerosis was not a prognostic factor with regard to patency of LITA or vein grafts. The absolute number of occluded LITA grafts was low but for venous grafts, intraoperative graft flow was a prognostic factor for intermediate term patency.

  • Emergency reintervention in patiens with acute graft failure following coronary artery bypass surgery

    by M Thielmann, G Marggraf, A Schmermund, P Massoudy, M Kamler, I Aleksic, U Herold, J Piotrowski, R Erbel, H Jakob

    Objectives: Acute graft failure after CABG is a life-threatening complication, which is proposed to be treated by emergent reintervention to limit myocardial damage, thus preserving ventricular function, which in turn is the most important determinant of patient outcome. Material and Methods: Between 01/2000 and 09/2003, coronary angiography was emergently performed in 71 of 3542 consecutive CABG patients with evidence of acute perioperative myocardial infarction (PMI) to elucidate mechanisms causing PMI, and to assess feasibility of subsequent reintervention. As a result, patients subsequently underwent acute PCI (group A), were taken to emergency (group B) or immediate reoperation (group C), or a reinterventional approach was renounced (group D). Results: PMI was caused by acute graft failure in 41/71 patients. Fifty-two out of 135 grafts were failing. Of these, 40 grafts were occluded, 7 grafts had subtotal stenotic anastomosis, and 5 grafts were kinked. Eleven of 41 patients (27%) were treated by subsequent PCI with stenting of native coronary arteries (7 LAD, 5 LCx), whereas 13 of 41 patients (32%) were readmitted to emergency (2.7±2.1h after angiography) or immediate reoperation (114±110h after angiography). Thirty-day and 1-year mortality was 18% (2/11) and 18% (2/11) in group A, 11% (1/9) and 22% (2/9) in group B, 50% (2/4) and 50% (2/4) in group C, and 18% (3/17) and 24% (4/17) in group D, respectively. Conclusions: Acute repeat angiography with subsequent reintervention in patients with PMI after CABG is a high-risk but reliable approach. If surgical redo is neccessary, patients should underwent re-CABG within a minimum of time.

  • Risk factor grading for prevention of coronary artery disease

    by R. Erbel, W. Siffert, S. Möhlenkamp, A. Schmermund

    Eine verbesserte Prävention und Therapie hat zu einem Abfall der kardialen Todesfälle in den westlichen Ländern geführt. In der Folge ist die Zahl der Patienten mit chronischer koronarer Herzerkrankung (KHK) gestiegen. Das neue Konzept der Prävention bei KHK zielt auf die Identifizierung des individuellen Risikos ab, das in drei Klassen - niedrig, mittelgradig, hoch - unterteilt wird. Die Risikoabschätzung stützt sich auf anamnestische, klinische und klinisch-chemische Daten. Auf dieser Grundlage erlauben die Tabellen der Europäischen Gesellschaft für Kardiologie eine semiquantitative Risikoberechnung, während die Algorithmen der Framingham- und PROCAM-Studien eine quantitative Berechnung ermöglichen. Wenn mit diesem Vorgehen keine sichere Festlegung des Risikos gelingt („intermediär”), erlauben bildgebende Verfahren, die Bestimmung des Knöchel-Arm-Index und die Messung des C-reaktiven Proteins eine weitergehende Beurteilung. Das therapeutische Vorgehen kann somit dem individuellen Risiko angepasst werden. Eine intensive, meist auch medikamentöse Therapie mit dem Ziel der möglichst weitgehenden Reduktion der Risikofaktoren wird bei nach den Risikotabellen bzw. -algorithmen definierten Hochrisiko-Personen (>2 % Risiko kardiale Ereignisse/Jahr) angestrebt. Findet sich auf dieser Grundlage ein intermediäres Risiko, so wird anhand von Zeichen der Arteriosklerose, z. B. Karotis-Plaques, Aortenaneurysma, transistorisch-ischämisch Attacke und/oder Koronarkalk, über die Therapie entschieden. Bei Nachweis einer ausgeprägten Arteriosklerose steht die intensive Therapie im Vordergrund, bei fehlenden Zeichen der Arteriosklerose kann aber oft auch von einer spezifischen Therapie abgesehen werden. Es ist zu hoffen, dass über die so erreichte individuelle Therapie eine weitere Abnahme der tödlichen Herzinfarkte erreicht wird und vor allem plötzliche und unverwartete Ereignisse vermieden werden können. Fazit: Die Abschätzung des individuellen KHK Risikos steht im Vordergrund der Risikostratifizierung. Neben der Bedeutung von kausalen, möglichen und prädisponierenden Risikofaktoren erlauben vor allem neue bildgebende Methoden, aber auch die Bestimmung des C-reaktiven Proteins, eine bessere Abschätzung des Risikos. Die Einleitung einer gezielten Therapie ermöglicht die Senkung des Herzinfarktrisikos, besonders die Vermeidung plötzlicher, unerwarteter Ereignisse.